About Our Product
Home / About
(patented and previously FDA Approved, EMA registered)
More information on Oxy-Rx™ can be found below.
Modified-Hemoglobin Protein Active Oxygen Carrier (m-HPAOC) s a safe, ultra-pure, effective, universally compatible, and rapidly deployed (RT Stable) material that provides tissue oxygentation via systematic OXYGEN "delivery".
Consistent, robust and reproducible supply, easy to store and transport with long shelf-life, universally compatible and readily available “fluid” oxygen support solution to preserve/sustain tissue perfusion and minimize cellular hypoxia and reverse ischemia.
Licensing/collaborative opportunity for completed technological design and a documented “digital” operational package of a modular manufacturing facility for maintaining equivalency of biological products between sites and with harmonization with competent authority.
01
Modified & stabilized oxygen active proteins as an injectable solution.
02
Chemically stabilized hemoglobin 7 g per 100 ml of bovine Hb (amino acid sequenced).
03
Manufactured as a purified extract from source-verified fresh drawn bovine blood.
04
Stabilized and packaged for long shelf live (5 years) at room temperature.
05
Suitable for all blood types, no need of blood typing in case of emergencies.
06
No Immunosuppression – invisible to the immune system.
07
Carrying Capacity - delivers oxygen within minute and halts acute-injury especially during a heart attack or stoke (tissue hypoxia).
08
Size is 1/1000 of normal RBC, capable of supplying oxygen in cases of major blood vessel occlusion, constriction or low flow blood environments.
09
Low viscosity (better circulation) for better perfusion at low pressures (limit or eliminate reperfusion injury).
10
Increasing Quality of Care – use during emergency and elective surgeries.
11
Advantages of a “Red Cell” Substitute (recreating the functionality of blood).
Two Critical Areas of Unmet Medical Needs and Opportunities with the Blood Supply
Systemic Oxygen Circulation and Delivery
Metabolic Regulation
Product Properties
For further information on OXY-Rx™ please contact us.
We would be happy to discuss it further.
0207 034 3300
We’d like to hear from you
Fitzrovia Hospital,
13-14 Fitzroy Square London, W1T 6AH
Please write to us
About
Markets
Press Releases
Contact